Literature DB >> 22262056

The role of CREB-H transcription factor in triglyceride metabolism.

Ann-Hwee Lee1.   

Abstract

PURPOSE OF REVIEW: Cyclic-AMP-responsive-element-binding protein H (CREB-H) is a transcription factor that is highly and selectively expressed in liver and small intestine. Here I summarize recent findings on the role of CREB-H in lipid metabolism. RECENT
FINDINGS: Recent studies have demonstrated that hepatic CREB-H is transcriptionally activated by fasting, and induces lipid metabolism genes, such as Apoa4, Apoa5, and Apoc2 apolipoproteins which exhibit stimulatory effects on lipoprotein lipase (LPL). Consistent with the essential role of LPL in triglyceride clearance, CREB-H-deficient mice showed hypertriglyceridemia, associated with defective production of these apolipoproteins and decreased LPL activity. DNA sequencing of the CREB3L3 gene (encoding CREB-H) identified multiple nonsynonymous mutations in CREB3L3 in individuals with extreme hypertriglyceridemia.
SUMMARY: Recent studies uncover a novel function of CREB-H in the regulation of triglyceride metabolism in rodents and humans. In liver and small intestine, CREB-H induces LPL coactivators, Apoa4, Apoa5, and Apoc2 that facilitate triglyceride clearance from plasma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262056      PMCID: PMC3366104          DOI: 10.1097/MOL.0b013e3283508fed

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  48 in total

1.  N-linked glycosylation is required for optimal proteolytic activation of membrane-bound transcription factor CREB-H.

Authors:  Chi-Ping Chan; To-Yuen Mak; King-Tung Chin; Irene Oi-Lin Ng; Dong-Yan Jin
Journal:  J Cell Sci       Date:  2010-03-31       Impact factor: 5.285

2.  OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes.

Authors:  Shinichi Kondo; Tomohiko Murakami; Kouko Tatsumi; Maiko Ogata; Soshi Kanemoto; Kumi Otori; Ken Iseki; Akio Wanaka; Kazunori Imaizumi
Journal:  Nat Cell Biol       Date:  2005-01-23       Impact factor: 28.824

Review 3.  HNF4α--role in drug metabolism and potential drug target?

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Curr Opin Pharmacol       Date:  2010-12       Impact factor: 5.547

Review 4.  Endocannabinoids in liver disease.

Authors:  Joseph Tam; Jie Liu; Bani Mukhopadhyay; Resat Cinar; Grzegorz Godlewski; George Kunos
Journal:  Hepatology       Date:  2011-01       Impact factor: 17.425

5.  Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1.

Authors:  Keisuke Yamamoto; Takashi Sato; Toshie Matsui; Masanori Sato; Tetsuya Okada; Hiderou Yoshida; Akihiro Harada; Kazutoshi Mori
Journal:  Dev Cell       Date:  2007-09       Impact factor: 12.270

6.  The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha.

Authors:  Hirosuke Danno; Kiyo-aki Ishii; Yoshimi Nakagawa; Motoki Mikami; Takashi Yamamoto; Sachiko Yabe; Mika Furusawa; Shin Kumadaki; Kazuhisa Watanabe; Hidehisa Shimizu; Takashi Matsuzaka; Kazuto Kobayashi; Akimitsu Takahashi; Shigeru Yatoh; Hiroaki Suzuki; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Biochem Biophys Res Commun       Date:  2009-12-16       Impact factor: 3.575

Review 7.  CIDE proteins and metabolic disorders.

Authors:  Jingyi Gong; Zhiqi Sun; Peng Li
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

8.  Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H.

Authors:  Jennifer Luebke-Wheeler; Kezhong Zhang; Michele Battle; Karim Si-Tayeb; Wendy Garrison; Sodhi Chhinder; Jixuan Li; Randal J Kaufman; Stephen A Duncan
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

Review 9.  Common and rare variants in multifactorial susceptibility to common diseases.

Authors:  Walter Bodmer; Carolina Bonilla
Journal:  Nat Genet       Date:  2008-06       Impact factor: 38.330

Review 10.  PPARalpha and dyslipidemia.

Authors:  Caroline Duval; Michael Müller; Sander Kersten
Journal:  Biochim Biophys Acta       Date:  2007-06-02
View more
  16 in total

1.  Cyclic AMP Response Element-binding Protein H (CREBH) Mediates the Inhibitory Actions of Tumor Necrosis Factor α in Osteoblast Differentiation by Stimulating Smad1 Degradation.

Authors:  Won-Gu Jang; Byung-Chul Jeong; Eun-Jung Kim; Hyuck Choi; Sin-Hye Oh; Don-Kyu Kim; Seung-Hoi Koo; Hueng-Sik Choi; Jeong-Tae Koh
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

2.  Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Ann-Hwee Lee
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

3.  Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.

Authors:  Jong-Gil Park; Xu Xu; Sungyun Cho; Ann-Hwee Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

4.  CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.

Authors:  Masami Shimizu-Albergine; Debapriya Basu; Jenny E Kanter; Farah Kramer; Vishal Kothari; Shelley Barnhart; Carissa Thornock; Adam E Mullick; Noemie Clouet-Foraison; Tomas Vaisar; Jay W Heinecke; Robert A Hegele; Ira J Goldberg; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

5.  Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Kyu Yeon Hur; Ann-Hwee Lee
Journal:  J Lipid Res       Date:  2014-03-05       Impact factor: 5.922

Review 6.  Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.

Authors:  Anna Wolska; Richard L Dunbar; Lita A Freeman; Masako Ueda; Marcelo J Amar; Denis O Sviridov; Alan T Remaley
Journal:  Atherosclerosis       Date:  2017-10-20       Impact factor: 5.162

7.  Fasting-induced G0/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids.

Authors:  Doris Jaeger; Gabriele Schoiswohl; Peter Hofer; Renate Schreiber; Martina Schweiger; Thomas O Eichmann; Nina M Pollak; Nadja Poecher; Gernot F Grabner; Kathrin A Zierler; Sandra Eder; Dagmar Kolb; Franz P W Radner; Karina Preiss-Landl; Achim Lass; Rudolf Zechner; Erin E Kershaw; Guenter Haemmerle
Journal:  J Hepatol       Date:  2015-02-27       Impact factor: 25.083

8.  Phosphorylation and SCF-mediated degradation regulate CREB-H transcription of metabolic targets.

Authors:  Sónia Barbosa; Suzanne Carreira; Daniel Bailey; Fernando Abaitua; Peter O'Hare
Journal:  Mol Biol Cell       Date:  2015-06-24       Impact factor: 4.138

9.  CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis.

Authors:  Jong-Gil Park; Xu Xu; Sungyun Cho; Kyu Yeon Hur; Myung-Shik Lee; Sander Kersten; Ann-Hwee Lee
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

10.  β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H.

Authors:  Yun Cheng; Wei-Wei Gao; Hei-Man Vincent Tang; Jian-Jun Deng; Chi-Ming Wong; Chi-Ping Chan; Dong-Yan Jin
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.